Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. 1994

Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
Pacific Northwest Research Foundation, Seattle, WA 98122.

There is a need for the development of new diagnostic tools for the early detection of prostate cancer. A candidate molecule for a new screening test is a prostate-specific membrane antigen (PSM) recognized by the monoclonal antibody 7E11.C5. We carried out studies aimed at identifying PSM in the serum of normal and benign prostatic hyperplasia (BPH) donors and patients with adenocarcinoma of the prostate, in order to judge whether the development of a serum assay using this marker was feasible. By Western blotting, we found significant levels of PSM in serum samples from prostatic cancer patients, in the seminal fluid of pooled normal donors, in BPH patients, and in normal male sera. Similar to prostate-specific antigen (PSA), PSM was present in seminal plasma in higher concentrations than in serum, and PSM levels in prostatic cancer patients were significantly higher than in normal controls. These data suggest that the development of an assay utilizing the PSM and new monoclonal antibodies directed against the antigen, could provide a feasible test for prostatic cancers.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012661 Semen The thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma. Seminal Plasma,Plasma, Seminal

Related Publications

Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
April 1998, Cancer research,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
July 1997, Cancer,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
January 1994, The Journal of urology,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
January 1995, Anticancer research,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
May 1995, The Western journal of medicine,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
May 1998, Urology,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
July 1995, The Prostate,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
January 2008, Urologic oncology,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
May 2021, Radiology,
Y P Rochon, and J S Horoszewicz, and A L Boynton, and E H Holmes, and R J Barren, and S J Erickson, and G M Kenny, and G P Murphy
October 1992, Clinical chemistry,
Copied contents to your clipboard!